M. Angerer-Shpilenya

RWTH Aachen University, Aachen, North Rhine-Westphalia, Germany

Are you M. Angerer-Shpilenya?

Claim your profile

Publications (4)1.78 Total impact

  • M. Angerer-Shpilenya · N.T. Gaisa · G. Jakse
    [Show abstract] [Hide abstract]
    ABSTRACT: Background Bowen’s disease and erythroplasia of Queyrat are intraepidermal neoplasias (carcinoma in situ) and are considered as preinvasive types of penile squamous cell carcinoma. The risk of progression to invasive cancer is low and such a process can last up to 20 years. Material and method Penis preservation and simultaneous complete excision of the tumour are strongly related to the quality of life of the patients and thereby represent the aim of the therapy. Local excision with reconstructive plastic surgery allows satisfactory aesthetic results without jeopardizing cancer control. Results The results of this treatment are comparable with those after Nd-YAG laser therapy. Local recurrence occurs in up to 33% also after years irrespective of the surgical strategy chosen. Conclusion A close follow-up with timely treatment of recurrences allows suitable tumour control without worsening the prognosis and is the most important requirement for an organ-preserving treatment of Bowen’s disease.
    No preview · Article · Mar 2010 · Der Urologe
  • M Angerer-Shpilenya · N T Gaisa · G Jakse
    [Show abstract] [Hide abstract]
    ABSTRACT: Bowen's disease and erythroplasia of Queyrat are intraepidermal neoplasias (carcinoma in situ) and are considered as preinvasive types of penile squamous cell carcinoma. The risk of progression to invasive cancer is low and such a process can last up to 20 years. Penis preservation and simultaneous complete excision of the tumour are strongly related to the quality of life of the patients and thereby represent the aim of the therapy. Local excision with reconstructive plastic surgery allows satisfactory aesthetic results without jeopardizing cancer control. The results of this treatment are comparable with those after Nd-YAG laser therapy. Local recurrence occurs in up to 33% also after years irrespective of the surgical strategy chosen. A close follow-up with timely treatment of recurrences allows suitable tumour control without worsening the prognosis and is the most important requirement for an organ-preserving treatment of Bowen's disease.
    No preview · Article · Nov 2009 · Der Urologe
  • M. Angerer-Shpilenya · G. Jakse
    [Show abstract] [Hide abstract]
    ABSTRACT: Die Indikation zur inguinalen Lymphadenektomie orientiert sich am klinischen Befund der Leistenregion und dem Risikoprofil des Primärtumors. Die pelvine Lymphadenektomie soll bei mehr als 2 Lymphknotenmetastasen oder extranodalem Befall durchgeführt werden. Obwohl es derzeit kein Standardprotokoll für die Chemotherapie gibt, ist sie präoperativ bei großen und/oder fixierten inguinalen Lymphknoten sowie bei in der Bildgebung sichtbaren iliakalen Lymphknoten angezeigt und der adjuvanten Chemotherapie vorzuziehen. Inguinal lymphadenectomy is performed according to the clinical features as well as the risk factors of the primary tumor. In cases involving more than two positive lymph nodes or extranodal growth as well as positive imaging, pelvic lymphadenectomy is indicated. Large or fixed inguinal nodes as well as iliac lymph nodes seen on computed tomography scanning are a good indication for neoadjuvant rather than adjuvant chemotherapy.
    No preview · Article · Jan 2009 · Der Urologe
  • M Angerer-Shpilenya · G Jakse
    [Show abstract] [Hide abstract]
    ABSTRACT: Inguinal lymphadenectomy is performed according to the clinical features as well as the risk factors of the primary tumor. In cases involving more than two positive lymph nodes or extranodal growth as well as positive imaging, pelvic lymphadenectomy is indicated. Large or fixed inguinal nodes as well as iliac lymph nodes seen on computed tomography scanning are a good indication for neoadjuvant rather than adjuvant chemotherapy.
    No preview · Article · Jan 2009 · Der Urologe

Publication Stats

2 Citations
1.78 Total Impact Points

Top Journals

Institutions

  • 2010
    • RWTH Aachen University
      • Institut für Pathologie
      Aachen, North Rhine-Westphalia, Germany
  • 2009
    • University Hospital RWTH Aachen
      Aachen, North Rhine-Westphalia, Germany